help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pohlenz, J.
Right arrow Articles by Costagliola, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pohlenz, J.
Right arrow Articles by Costagliola, S.
Right arrowPubmed/NCBI databases
*Genetics Home Reference
The Journal of Clinical Endocrinology & Metabolism Vol. 85, No. 7 2366-2369
Copyright © 2000 by The Endocrine Society

Special Articles

Failure of Membrane Targeting Causes the Functional Defect of Two Mutant Sodium Iodide Symporters1

Joachim Pohlenz2, Laurence Duprez, Roy E. Weiss, Gilbert Vassart, Samuel Refetoff and Sabine Costagliola

Departments of Medicine (J.P., R.E.W., S.R.) and Pediatrics (J.P., S.R.) and the J. P. Kennedy, Jr., Mental Retardation Research Center (S.R.), University of Chicago, Chicago, Illinois 60637-1470; Department of Medical Genetics (G.V., L.D.) and Institute of Interdisciplinary Research (G.V., L.D., S.C.), Free University of Brussels, Campus Erasme, 1070 Brussels, Belgium

Address all correspondence and requests for reprints to: Dr. Samuel Refetoff, University of Chicago, 5841 South Maryland Avenue, Chicago, Illinois 60637. E-mail: refetoff{at}medicine.bsd.uchicago.edu

Molecular cloning of the sodium/iodide symporter (NIS) allowed identification of NIS gene mutations in patients with iodide trapping defect. Whereas various mutant human (h) NIS molecules display loss of function when expressed by transfection in mammalian cells, the precise mechanism(s) responsible for the functional abnormality of these proteins remains unknown. With the aim to explore these mechanisms in three natural hNIS mutants identified previously in patients with iodide trapping defect (Q267E, S515X, and C272X), we have prepared tools allowing direct measurement of the protein at its normal location in the plasma membrane.

A COS-7 cell line was made by transfection that stably expressed high levels of wild-type hNIS. It was used to screen by flow cytometry monoclonal antibodies (mAbs) prepared from mice immunized against hNIS. Genetic immunization was performed by im injection of a wild-type hNIS complementary DNA construct, because this procedure has demonstrated the ability to produce antibodies recognizing native membrane proteins. One mAb that recognized an epitope of hNIS exposed on the extracellular side of the plasma membrane was selected for further studies. The epitope was localized on the sixth putative extracellular loop of the protein on the basis that the mAb did not recognize rat NIS, which exhibits major sequence differences in this segment.

When this mAb was used to test by flow cytometry the expression of the three mutant hNIS proteins in transfected COS-7 cells, it detected similar amounts of wild-type, Q267E, and the S515X hNIS molecules in permeabilized cells. In contrast, only the wild-type hNIS was detected at the surface of nonpermeabilized cells. The C272X hNIS truncation mutant was not detected in intact or permeabilized cells. This is consistent with the absence of the mAb epitope from this mutant, which is expected to lack the sixth extracellular loop. Our data demonstrate that faulty membrane targeting is implicated in the mechanisms causing iodide trapping defect in the Q267E and S515X natural hNIS mutants.




This article has been cited by other articles:


Home page
 J EndocrinolHome page
A. Fierabracci, M. A. Puglisi, L. Giuliani, S. Mattarocci, and M. Gallinella-Muzi
Identification of an adult stem/progenitor cell-like population in the human thyroid
J. Endocrinol., September 1, 2008; 198(3): 471 - 487.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
K. Krause, S. Karger, A. Schierhorn, S. Poncin, M.-C. Many, and D. Fuhrer
Proteomic Profiling of Cold Thyroid Nodules
Endocrinology, April 1, 2007; 148(4): 1754 - 1763.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
W. Li, G. M. Venkataraman, and K. B. Ain
Protein Synthesis Inhibitors, in Synergy with 5-Azacytidine, Restore Sodium/Iodide Symporter Gene Expression in Human Thyroid Adenoma Cell Line, KAK-1, Suggesting Trans-Active Transcriptional Repressor
J. Clin. Endocrinol. Metab., March 1, 2007; 92(3): 1080 - 1087.
[Abstract] [Full Text] [PDF]

Home page
 Eur J EndocrinolHome page
G. Riesco-Eizaguirre and P. Santisteban
A perspective view of sodium iodide symporter research and its clinical implications.
Eur. J. Endocrinol., October 1, 2006; 155(4): 495 - 512.
[Abstract] [Full Text] [PDF]

Home page
 Endocr Relat CancerHome page
G Riesco-Eizaguirre, P Gutierrez-Martinez, M A Garcia-Cabezas, M Nistal, and P Santisteban
The oncogene BRAF V600E is associated with a high risk of recurrence and less differentiated papillary thyroid carcinoma due to the impairment of Na+/I- targeting to the membrane.
Endocr. Relat. Cancer, March 1, 2006; 13(1): 257 - 269.
[Abstract] [Full Text] [PDF]

Home page
 JNMHome page
D. D. Vadysirisack, D. H. Shen, and S. M. Jhiang
Correlation of Na+/I- Symporter Expression and Activity: Implications of Na+/I- Symporter as an Imaging Reporter Gene
J. Nucl. Med., January 1, 2006; 47(1): 182 - 190.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
A. De la Vieja, C. S. Ginter, and N. Carrasco
Molecular Analysis of a Congenital Iodide Transport Defect: G543E Impairs Maturation and Trafficking of the Na+/I- Symporter
Mol. Endocrinol., November 1, 2005; 19(11): 2847 - 2858.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
Z. Zhang, Y.-Y. Liu, and S. M. Jhiang
Cell Surface Targeting Accounts for the Difference in Iodide Uptake Activity between Human Na+/I- Symporter and Rat Na+/I- Symporter
J. Clin. Endocrinol. Metab., November 1, 2005; 90(11): 6131 - 6140.
[Abstract] [Full Text] [PDF]

Home page
 J. Med. Genet.Home page
S M Park and V K K Chatterjee
Genetics of congenital hypothyroidism
J. Med. Genet., May 1, 2005; 42(5): 379 - 389.
[Abstract] [Full Text] [PDF]

Home page
 J. Cell Sci.Home page
A. De la Vieja, C. S. Ginter, and N. Carrasco
The Q267E mutation in the sodium/iodide symporter (NIS) causes congenital iodide transport defect (ITD) by decreasing the NIS turnover number
J. Cell Sci., February 15, 2004; 117(5): 677 - 687.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A.-C. Gerard, C. Daumerie, C. Mestdagh, S. Gohy, C. de Burbure, S. Costagliola, F. Miot, M.-C. Nollevaux, J.-F. Denef, J. Rahier, et al.
Correlation between the Loss of Thyroglobulin Iodination and the Expression of Thyroid-Specific Proteins Involved in Iodine Metabolism in Thyroid Carcinomas
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4977 - 4983.
[Abstract] [Full Text] [PDF]

Home page
 Endocr. Rev.Home page
O. Dohan, A. De la Vieja, V. Paroder, C. Riedel, M. Artani, M. Reed, C. S. Ginter, and N. Carrasco
The Sodium/Iodide Symporter (NIS): Characterization, Regulation, and Medical Significance
Endocr. Rev., February 1, 2003; 24(1): 48 - 77.
[Abstract] [Full Text] [PDF]

Home page
 EndocrinologyHome page
J. Van Sande, C. Massart, R. Beauwens, A. Schoutens, S. Costagliola, J. E. Dumont, and J. Wolff
Anion Selectivity by the Sodium Iodide Symporter
Endocrinology, January 1, 2003; 144(1): 247 - 252.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. Kosugi, H. Okamoto, A. Tamada, and F. Sanchez-Franco
A Novel Peculiar Mutation in the Sodium/Iodide Symporter Gene in Spanish Siblings with Iodide Transport Defect
J. Clin. Endocrinol. Metab., August 1, 2002; 87(8): 3830 - 3836.
[Abstract] [Full Text] [PDF]

Home page
 Mol. Endocrinol.Home page
O. Dohan, M. V. Gavrielides, C. Ginter, L. M. Amzel, and N. Carrasco
Na+/I- Symporter Activity Requires a Small and Uncharged Amino Acid Residue at Position 395
Mol. Endocrinol., August 1, 2002; 16(8): 1893 - 1902.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
A.-C. Gerard, M.-C. Many, C. Daumerie, S. Costagliola, F. Miot, J. J. M. DeVijlder, I. M. Colin, and J.-F. Denef
Structural Changes in the Angiofollicular Units between Active and Hypofunctioning Follicles Align with Differences in the Epithelial Expression of Newly Discovered Proteins Involved in Iodine Transport and Organification
J. Clin. Endocrinol. Metab., March 1, 2002; 87(3): 1291 - 1299.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
M. Tonacchera, P. Viacava, P. Agretti, G. de Marco, A. Perri, C. di Cosmo, M. de Servi, P. Miccoli, F. Lippi, A. G. Naccarato, et al.
Benign Nonfunctioning Thyroid Adenomas Are Characterized by a Defective Targeting to Cell Membrane or a Reduced Expression of the Sodium Iodide Symporter Protein
J. Clin. Endocrinol. Metab., January 1, 2002; 87(1): 352 - 357.
[Abstract] [Full Text] [PDF]

Home page
 J. Clin. Endocrinol. Metab.Home page
S. M. Jhiang
A Monoclonal Antibody Recognizing the Extracellular Domain of Human Na+/I- Symporter and Its Potential Applications
J. Clin. Endocrinol. Metab., July 1, 2000; 85(7): 2364 - 2365.
[Full Text]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2000 by The Endocrine Society